Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;13(1):8-14.
doi: 10.1016/j.clml.2012.09.002. Epub 2012 Oct 27.

Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience

Martin H Voss  1 , Matthew A Lunning, Jocelyn C Maragulia, Esperanza B Papadopoulos, Jenna Goldberg, Andrew D Zelenetz, Steven M Horwitz
Affiliations

Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience

Martin H Voss et al. Clin Lymphoma Myeloma Leuk. 2013 Feb.

Abstract

Introduction: Hepatosplenic T-cell lymphoma is a rare form of extranodal non-Hodgkin lymphoma, first recognized as a distinct entity in the Revised European-American Lymphoma classification. Typical presentation includes lymphomatous infiltration of spleen and liver, and peripheral lymphadenopathy is rarely seen. The prognosis is almost uniformly poor, and there are no prospective studies of treatment of HSTCL.

Patients and methods: For this report, we conducted a retrospective review of all pts who underwent treatment for HSTCL at our institution. Individual chart review was performed to report clinical presentation, management, and outcome.

Results: We identified 14 pts with HSTCL managed at our center, 7 of which remain alive with median follow-up of 65.6 months. Six of 7 received alternative induction chemotherapy regimens such as ICE (ifosfamide, carboplatin, etoposide) or IVAC (ifosfamide, etoposide, high-dose cytarabine) as opposed to CHOP and all surviving pts had proceeded to undergo either autologous or allogeneic SCT.

Conclusion: Our results suggest that use of non-CHOP induction regimen and early use of high dose therapy and SCT consolidation may translate to improved survival for pts with HSTCL.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have stated that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Progression-Free Survival and Overall Survival. Kaplan-Meier Curve of Progression-Free Survival and Overall Survival in Our Cohort
Figure 2
Figure 2
Survival per IPI. Kaplan-Meyer Curve Stratified in Groups with International Prognostic Index (IPI) 0–2 Versus 3–5 Demonstrating No Significant Difference in Overall Survival
See this image and copyright information in PMC

References

    1. Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75:2213–9. - PubMed
    1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma Study Group. Blood. 1994;84:1361–92. - PubMed
    1. Harris NL, Jaffe ES, Diebold J, et al. Lymphoma classification–from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000;11(Suppl 1):3–10. - PubMed
    1. Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol. 2007;127:869–80. - PubMed
    1. Gaulard P, Belhadj K, Reyes F. Gammadelta T-cell lymphomas. Semin Hematol. 2003;40:233–43. - PubMed

MeSH terms